Latest industry research report on: Diabetes care market comprises of technologies, devices and therapeutics markets in relation to diabetes. Insulin is a hormone made by the pancreas that acts like a key to let glucose from the food we eat pass from the blood stream into the cells in the body to produce energy. Some of the major factors driving the growth of this market are the rising incidences of chronic lifestyle diseases across the globe, growing aging population, and increasing usage of point-of-care testing and personalized medicine. CROS NT looks at the growing diabetes market and what is driving innovation in this sector. This was approximately 11 percent of the total healthcare expenditures in adults age 20 to 79. This is the 2nd edition report on Blood Glucose Device Market by iGATE RESEARCH. Diabetics have inadequate blood sugar control which can lead to complications including nerve and kidney damage.
Invokana, which is marketed by Johnson & Johnson, is one of the key players in the disease cluster. New products in the pipeline and strong sales for its existing diabetes meds could move the company closer to its goal of doubling sales in the next 10 years. While the focus of an artificial pancreas is to manage the disease and make glucose monitoring and insulin intake automatic, there are lesser known efforts aimed at tackling diabetes differently. However, obesity pipeline activity is set to remain markedly low, despite a patient population of epidemic proportions.